Archives and past articles from the Philadelphia Inquirer, Does fisher investments drug test Daily News, and Philly. 5 9 0 14 6. The home of over 5. Easily clip, save and share what you find with family and friends.

Easily download and save what you find. Your source for local news, sports, high school sports and weather in and around Jefferson City, Columbia, Fulton and the Lake of the Ozarks. Your Opinion: Who pays for Rock Island Trail? This document may not be reprinted without the express written permission of News Tribune Publishing.

What are you looking for? Since 1981, healthcare has been a consistent cornerstone of GTCR’s investment strategy. The firm’s long history in the industry and our deep domain knowledge create opportunities to partner with exceptional management leaders and to generate unique perspective on the underlying trends that drive the healthcare industry today. GTCR has extensive experience investing across the healthcare and life sciences industries, including branded and generic pharmaceuticals, medical devices, life science tools and diagnostics, healthcare information technology, providers, payors, distribution and ancillary services.

We continue to identify attractive opportunities to invest capital across these sectors of healthcare—driven by the positive, long-term healthcare utilization trends and an evolving industry landscape that increasingly values new business models that emphasize both clinical outcomes and cost-containment. Recent portfolio activity and updates on our Healthcare investments. AMRI is a top-ten global contract research, development and manufacturing organization for biopharmaceutical companies. Mulhern joined AMRI as Chief Executive Officer in January 2018, after previously serving on AMRI’s Board of Directors. Prior to joining AMRI, Mr.

Mulhern served as CEO and Executive Chairman of Sterigenics International from 2011 through 2017, during which time he built the company into a leading global provider of contract sterilization, gamma technologies and medical isotopes. Mulhern has now led four companies backed by private equity firm GTCR, where he has established a track record of operational excellence, quality customer service and global growth. In addition to serving as CEO of AMRI and Sterigenics, Mr. Mulhern previously served as CEO and Chairman of Fairmount Food Group and American Sanitary. Before joining American Sanitary, he held senior executive roles at Baxter International and Alliant Foodservice.